In the lockdown, while I was on regular OPD and ICU rounds at a COVID hospital, I started noticing some mild symptoms of the Coronavirus infection. Being in the medical field and considering the severity of the pandemic situation then, I was very careful and cautious, and observed the symptoms closely. The symptoms persisted and I had to self-quarantine until the medical test reports came. It was important for me to isolate myself from the rest of the medical team and prevent the spread of the virus. Finally, the report came: I was COVID positive! Stunned and slightly devastated; I broke the news to my family who could not believe it either. As a doctor, I could only treat, comfort and empathize with the COVID patients undergoing treatment; completely isolated from their loved ones. But now, I could actually feel the uncertainty of the situation. I was hospitalized and continued to experience body-ache during the admission. It was a stressful situation where I felt anxious and stressed about everything. My CT scan reports showed mild lung infection on the day of admission but as the cytokines storm developed, my lungs were 76 % damaged in 3-5 days and I was short of breath and my oxygen level deteriorated to less than 80.  I was shifted to an ICU with high-flow oxygen and was on a BiPap machine which I had purchased a few weeks ago for the hospital and never imagined that I would be using myself one day.

“Lifestyle advice often asks patients to fight powerful evolutionary...

Why India Must Urgently Reinvent Healthcare for a 100-Year...

The Indian Pharmaceutical Market (IPM) was valued at Rs. 10,278 crs in the month of September 2016 clocking a strong 10% growth over same period last year (SPLY). On a MAT September basis, the industry was valued at Rs. 111,022 crores and reflected a 13% growth with volumes contributing around 40% of this growth and New Introductions playing an important role with around 38% contribution to the overall growth.

Why Indian hospitals must go beyond treatment to build...

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive...

The story of Healthium is not just one of...

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive...

The story of Healthium is not just one of...

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive...

The story of Healthium is not just one of...

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive...

The story of Healthium is not just one of...